Synchrobreathe
* Click to view the content
1. Real-world study evaluating the efficacy and safety of
formoterol/budesonide delivered through a breath-actuated inhaler in
COPD patients (NAPCON Delhi 2023, ERS 2023 and NAPCON Hyderabad 2023,
Drugs Real World Outcomes Journal)
2. Adherence to BA-pMDI, MDI, and DPI Inhalers and their impact on
COPD Assessment Test and Asthma Control Test (AICA Study) (NAPCON
Coimbatore 2024, NAPCON Pune 2025 and ERS 2025)
3. Breath-actuated inhalers: A new option for the management of acute
asthma exacerbations in children (RESPICON Kolkata 2023 and ERS 2023)
4. Clinical correspondence: Usage of a novel inhaler device for the
management of asthma in children with special needs (Pediatric
Pulmonology Journal, August 2023)
5. In-vitro Performance Evaluation of three
Formoterol/Glycopyrronium/Budesonide Inhalers (ERS India Summit,
Mumbai 2025)